<\/a><\/p>\n <\/p>\n Journal of Bone and Soft Tissue Tumors (JBST) is open access, Double-blind peer-reviewed journal with contributions from all across the globe. Publishing articles related to care and research in field of bone and soft tissue cancers.<\/p>\n Bone and Soft tissue cancers is a rapidly developing area both in terms of diagnostic modalities and innovation in treatment protocols thus increasing the life as well as improving the quality of life. Although number of patients may be comparatively low but the impact of these diseases is quite great and we believe this area requires an independent journal to provide single platform to publish all research and development in this important area..<\/p>\n Journal of Bone and Soft Tissue Tumors (JBST) is the First of its kind journal where a complete journal is dedicated to Bone and Soft Tissue tumors. The submission format is kept very simple and practical.<\/p>\n Aims & Scope of the Journal<\/strong><\/p>\n Journal of Bone and Soft Tissue Tumors (JBST) will focus to integrate knowledge from all resources and create a common wisdom pool. The focus of the journal will be clinical, medical and surgical aspects of orthopaedic oncology but will also extend to include Basic sciences, clinical trials, molecular biology; genetics, pathology; radiodiagnosis, interventional radiology, radiotherapy, biomechanics; biomaterials; nanotechnology; and also special prosthesis designs. This journal primarily aims to cater to clinicians, researchers and health-care providers whose focus is on the understanding and treatment of bone and soft tissue tumors<\/p>\n Journal of Bone and Soft Tissue Tumors (JBST) will be an international peer review Journal with contributions from all across the globe.<\/p>\n What is different about the Journal of Bone and Soft Tissue Tumors (JBST)?<\/p>\n The entire format of the Journal will be one of \u2018Integration\u2019 with basic science, clinical trials, clinical research, case based discussion, evidence based medicine, expert opinion, Videos, keynote presentations and web resources, all aiming together to \u2018Translate\u2019 into betterment of care in Bone tumors. The submission format is kept very simple and practical and accepted articles will be in form of case reports, case series, original articles, technical notes and also metanalysis and systematic review of literature with complications or complicated cases in focus.<\/p>\n The Journal will include many focused and novel features including those listed below:<\/p>\n GUEST EDITORIALS, INTERVIEWS & EXPERT OPINIONS: These will be invited from eminent clinician\/researcher who have vast experience in field of bone tumors<\/p>\n CASE REPORT: A single case that highlights a particular complication along with treatment strategy and methods of management of a unique\/difficult\/complicated case<\/p>\n ORIGINAL ARTICLES: Original articles on any study focused on surgical or nonsurgical treatment modality of bone and soft tissue tumors<\/p>\n BASIC SCIENCE: Original and review articles from field of basic research in bone tumors including genetic studies, histopathogical developments and biomechanical studies<\/p>\n PHARMACOLOGICAL STUDIES: Especially clinical trials and articles related to innovative drug and medical management of bone and soft tissue tumors.<\/p>\n ALLIED SCIENCES: articles from allied branches like radiotherapy, radiodiagnostics, interventional radiology and rehabilitation sciences would also be accepted in JBST<\/p>\n TECHNICAL NOTES: Specific technical tricks and pearls or improvisations during surgery or conservative management of a patient can be published in a more pictorial form including videos and graphic diagrams<\/p>\n CASE IMAGE: Only a single image of a unique case can spark a full-fledged discussion on diagnosis and treatment of it. This section will aim to publish such images with detailed descriptions of the case<\/p>\n COMPLEX & COMPLICATED CASES: A primarily complex or complicated cases which is difficult to manage with multiple factors in clinical decision making. Management protocol with decision making flowchart will be included in this<\/p>\n CASE STUDY: The other spectrum to primary complex case is multiply operated case that now presents with unique decision making scenarios which are complex and need personalized thought process and management plan. Most focus will be on the rationale of management and ultimate result. Patient perspective will also form a part of every case study<\/p>\n LITERATURE REVIEW: In form of special review, metanalysis or systematic reviews focussed on one particular complications or complicated cases.<\/p>\n JOURNAL REVIEW: A review of articles related to orthopaedic complications that are published in last one month in other Journals<\/p>\n LETTER TO EDITOR: On any topic or article that is published in the journal. Readers can share their own similar cases as published in the Journal<\/p>\n <\/p>\n Acceptance or Rejection<\/strong><\/p>\n Manuscripts are judged on the interest and importance of the topic, intellectual and scientific strength, clarity of presentation, and relevance to Journal of Bone and Soft Tissue Tumors (JBST) readers.<\/p>\n Complaints and Appeals<\/strong><\/p>\n This procedure applies to complaints about the publishing policies, procedures and\/or actions of the Journal of Bone and Soft Tissue Tumors\u2019 Editorial staff. This complaint must relate to content or a procedure that was the responsibility of the JBST or its Editor.<\/p>\n If the authors strongly believe that their manuscript was wrongly rejected, they can register an appeal with the Journal by emailing detailed explanation to editor.jbst@gmail.com . The appeals will be acknowledged by the Editorial office and will be investigated in an unbiased manner. While under appeal, the said manuscript should not be submitted to other journals. The final decision rests with the Editor-in-Chief, and second appeals are not considered.<\/p>\n The Journal only accepts complaints through the above-mentioned e-mail, as this provides a reliable trail. All complaints are acknowledged at the earliest. The complaint would be followed-up in an unbiased manner and be handled by the person to whom they are made, if possible. The Journal aims to resolve any complaint raised within 2\u20134 weeks; however, if that is not possible, an interim response would be provided until the complaint is resolved.<\/p>\n ________________________________________<\/p>\n Contact Journal of Bone and Soft Tissue Tumors (JBST): Instructions for Authors<\/strong><\/p>\n Manuscript Submission<\/strong><\/p>\n Authors should submit their manuscripts online using the online electronic submission system \u2018Scripture\u2019 developed for this journal by IORG. Please Click Here if you are ready to Submit your article.<\/p>\n Article Charges: Article Charges: Since the Journal is Open access will allow us to make your article free to access and download by everyone and will invite better citation and wide outreach. There are no charges for submitting the manuscript or for peer review and decision on the manuscript. Processing charges will be INR 3500 (for papers from India) and 150 USD (for foreign articles). Authors will usually receive a decision on their manuscript within 6-8 weeks.<\/p>\n All manuscripts are to be submitted via the Journal submission software \u2018Scripture\u2019 on the website www.jbstjournal.com Any other query regarding article formatting for submission process can also be mailed to All manuscripts are to be submitted via the Journal submission software \u2018Scripture\u2019 on the website www.jbstjournal.com<\/a> Any other query regarding article formatting for submission process can also be mailed to editor.jbst@gmail.com<\/a><\/p>\n Authors Agreement<\/strong><\/p>\n Authors who publish with this journal agree to the following terms”<\/p>\n 1. The author(s) allow the right to first publication of the article entitled to the Journal of Bone and Soft Tissue Tumors in the event the work is published.<\/p>\n 2.The author(s) warrant(s) that the article is original, is not under consideration by another journal, and has not been published previously. The authors accept responsibility for releasing this material.\u201d<\/p>\n 3.In case a paper has previously been presented or published as a poster in a national or international conference, the author(s) must make a full disclosure to the editor about it. Such papers are still eligible for publication in the journal provided the author(s) disclose this during their submission.<\/p>\n 4. The authors state that a valid informed consent is taken from all human subjects that are included in their articles<\/p>\n For all purposes, the copyright of the articles belongs to the authors.<\/p>\n Copyright Letter\/Form:<\/strong> \u00a0Download Here<\/a><\/p>\n Patent Consent Form:<\/strong> Download Here<\/a><\/p>\n Copyright Policy:<\/strong> The entire contents of the Journal of Bone and Soft Tissue Tumors are protected under India and international copyrights. However, the Journal grants to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, perform and display the work publicly and to make and distribute derivative works in any digital medium for any reasonable non-commercial purpose, subject to proper attribution of authorship and ownership of the rights. The journal also grants the right to make small numbers of printed copies for their personal non-commercial use under Creative Commons Attribution-Non-Commercial-Share Alike 4.0 International Public License. https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/\u00a0<\/a><\/p>\n Conflict-of-interest Statement<\/strong><\/p>\n All authors are expected to disclose any commercial affiliations as well as consultancies, stock ownership, or patent-licensing arrangements that could be considered to pose a conflict of interest regarding the submitted article. A conflict-of-interest statement will be forwarded to the corresponding author for signature upon acceptance of the manuscript. The signature of all authors is required. No article will be published until return of the completed form to the journal office.<\/p>\n Download Conflict of Interest form: Download Here<\/p>\n <\/p>\n Conflict of Interest forms are according to Guidelines by the International Committee of Medical Journal Editors and Each Authors details have to be filled separately and submitted with the manuscript. Plagiarism is not permitted and Journal will check every article for plagiarism using \u2018iThenticate\u2019 and google search.<\/p>\n Article submission Charges: <\/strong>None<\/p>\n Article Publishing charges:<\/strong> 3500 INR or 150 $ (for international articles). The publishing charges have to be paid only on acceptance of the article]<\/p>\n Make payment Here<\/strong><\/a><\/p>\n Instructions for Manuscript Preparation<\/strong><\/p>\n Manuscripts should be written in English. Authors whose native language is not English should seek the assistance of a colleague who is a native English speaker and familiar with the field of the work. Authors are advised to follow the recommendations in the \u201cUniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication\u201d proposed by the International Committee of Medical Journal Editors (www.icmje.org). Manuscripts must be typed double-spaced with wide margins on A4 paper. The manuscript parts should be in the following order, with each section beginning on a new page: title page, abstract, text, acknowledgments, references, tables, figure legends, and figures. Number all lines in a continuous manner and number all pages in the bottom right corner beginning with the title page. For reports on randomized control studies, authors should refer to the CONSORT statement (www.consort-statement.org). Standard abbreviations and SI units should be used. Define abbreviations at first appearance in the text, figure legends, and tables, and avoid their use in the title and abstract. Use generic names of drugs and chemicals.<\/p>\n Submission Formats<\/strong><\/p>\n Journal of Bone and Soft Tissue Tumors (JBST) accepts the following formats of articles<\/p>\n Description of various formats is provided below<\/p>\n Perspective<\/strong>s \u2013 A clinical overview of a common topic with the aim to share with the reader the recent update and current state of affairs<\/p>\n Insights<\/strong> – Invited article from an Expert in the Field specially focusing on their area of Research or Interest<\/p>\n \u00a0Interviews<\/strong> \u2013 Academicians and Researchers across the world will get a chance to feature in our interview section and share their views<\/p>\n Master Class<\/strong> \u2013 In this feature, we will invite a \u2018Master\u2019 to demonstrate videos or pictorial demonstrations of surgical techniques or concepts.<\/p>\n Innovations<\/strong>: An innovative concept or an Idea that provides a new perspective. This needs to send directly to the editorial email and after editorial review, it will be sent for peer review. 1000 words article describing the new concept, implant, protocol, or surgical modification should be accompanied with a note of how this will be clinically relevant.<\/p>\n Burning Questions:<\/strong> Opinion\/Counter opinions from experts or group of experts on selected topics<\/p>\n Original Articles<\/strong>: include case series, comparative trials, epidemiological studies, and RCT\u2019s<\/p>\n Case Reports:<\/strong> Have been detailed below and all the remaining formats follow similar guidelines as case reports<\/p>\n Case Image:<\/strong> is the description of a single Image that has an unique learning point<\/p>\n Technical Note and Video Technique:<\/strong> detailed description of a new technique or improvisation of an old technique<\/p>\n \u00a0Surgical Tips:<\/strong> Small surgical tips and pearls are invited for this section. Pictures are essential and video will be preferable<\/p>\n Case Study:<\/strong> This new format combines the level V evidence with Clinical Decision Making (CDM). It focuses on getting the thought process of the treating surgeon when dealing with a complex\/complicated case<\/p>\n \u00a0Case Approach:<\/strong> This is a new but invited-only section. We will invite an expert to describe to his approach to a particular case scenario with literature and rationale behind the approach<\/p>\n Clinical Perspective:<\/strong> this special section will publish specific learning points or experiences which the authors can share with the readers. The only essential point is that this perspective should be clinically relevant and rationally acceptable. This need not be with details of management or follow-up of the case. The idea is to provide a platform for the publication of these important and clinically relevant learning points. A single-page write-up of fewer than 1000 words will be accepted.<\/p>\n \u00a0Letter to Editor:<\/strong> on articles in Journal of Bone and Soft Tissue Tumors (JBST). Letters should be typed double-spaced and limited to 1000 words. A copy of the letter will be sent to the previous article\u2019s author(s) to invite a response.<\/p>\n \u00a0Letter to Experts:<\/strong> Journal of Bone and Soft Tissue Tumors (JBST) will soon be creating an Expert panel of surgeons. Readers of JBST can ask queries regarding complicated cases to our Experts. These queries will be answered by experts and the Orthopaedic Research Group will add a literature review to this expert opinion and the article will be peer-reviewed and published in 15 days.<\/p>\n Photo-Article<\/strong>: Pictorial articles which will be an easy read with most important message highlight<\/p>\n Following files will be essential for submission of any kind of article<\/p>\n The details of formatting these files are provided below.<\/p>\n Manuscripts submitted to the Journal of Bone and Soft Tissue Tumors (JBST) must be submitted in the format described below. Articles that do not meet the journal’s style will not be peer-reviewed or considered for publication. All articles should be no more than 3500 words long with a maximum of 50 references and 10 figures. Manuscripts should also contain an abstract of up to 350 words. The article will only be accepted for peer review in the following format:<\/p>\n Cover Page<\/p>\n Title page<\/p>\n Abstract<\/p>\n Keywords<\/p>\n Introduction<\/p>\n Material and Methods<\/p>\n Results:<\/p>\n Complications:<\/p>\n Discussion:<\/p>\n Conclusions:<\/p>\n Clinical Relevance:<\/p>\n References:<\/p>\n Illustrations and figures:<\/p>\n Figure legends (if any):<\/p>\n Additional data files (if any):<\/p>\n List of abbreviations used (if any):<\/p>\n Conflict of interests:<\/strong> To be downloaded from the website and a signed copy scanned and submitted along with manuscript.\u00a0 \u00a0[Download Here ]\u00a0<\/a><\/p>\n <\/p>\n Manuscripts should be submitted in Microsoft Word Document format<\/p>\n Cover Letter:<\/strong> This is the official letter written to editors by the author, where they can inform the editorial board about the significance of their study. They can also inform regarding special situations like shared data with another study or long-term follow-up of the already published articles. This also provides the chance for authors to interact directly with the editorial board and put up any specific point for considerations like more number of authors, manuscript exceeding word count, or figure count.<\/p>\n Title Page: <\/strong>The title should be concise and informative to make electronic retrieval of the manuscript both effective and specific. Include important information such as the study design, i.e., clinical or basic, and in particular, indicate if the study is a randomized control trial. A running title not exceeding 35 letters and spaces should be provided.<\/p>\n Example of Title Page<\/p>\n The first page of the manuscript should be a dedicated title page, including the title of the article. The title should include the study design, i.e. Case report. For example<\/p>\n Authors Names should appear in sequence that will be final, with superscript numbers mentioning authors affiliations<\/p>\n Author Name A1<\/sup>, Author Name B2<\/sup>, Author Name C3*<\/sup><\/p>\n Address: 1<\/sup> Full designation, degree, and postal address of author A; 2<\/sup> Full designations, degree and postal address of author B; 3 <\/sup>Full designations, degree and postal address of author C<\/p>\n * Corresponding author should be indicated with an asterisk.<\/p>\n The full names, institutional addresses, and email addresses of all authors must be included on the title page. No other information should be included on this page.<\/p>\n The page should contain the article title, the full names of the authors including only major qualifications such as M.D. or Ph.D., and the complete postal address of the department and institution where the work was done. Designate one author as a correspondent and supply his or her complete postal address, telephone number, fax number, and e-mail address. If the name or address for offprint requests is different, this should be stated. Every person listed as an author should have materially participated in the design, execution, and analysis of the study and should verify the accuracy of the entire manuscript before its submission. No more than 6 authors can be included on the title page. Lesser contributors may be noted in an acknowledgment section at the end of the manuscript.<\/p>\n Authorship criteria are as per the ICMJE Guidelines<\/strong> and include Authorship credit should be based only on substantial contributions:<\/p>\n For an original article the number of contributors should not exceed six; for case reports, the letter to the Editor, and review articles, the number of contributors should not exceed four. A justification should be included if the number of contributors exceeds these limits.<\/p>\n Only those who have done substantial work in a particular field can write a review article. A short summary of the work done in the field of review should accompany the manuscript.<\/p>\n Example to state Author’s Contributions<\/strong><\/p>\n We suggest the following kind of format (please use initials to refer to each author’s contribution):<\/p>\n \u201cFC analyzed and interpreted the patient data regarding the fracture disease and the stiffness.\u00a0 RH performed the histological examination of the callus and was a major contributor in writing the manuscript. All authors read and approved the final manuscript.\u201d<\/p>\n All contributors who do not meet the criteria for authorship should be listed in an acknowledgments section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided only general support.<\/p>\n Blinded Submission<\/strong><\/p>\n Author information should not be included in the main document. Authors should submit the title page, the main document, and the Pictures separately. To ensure blinding, authors should not include in the abstract or text the name or initials of the authors or the institution at which the study was performed. Refer to your own published work in the third person. Use \u201cIn the previous work of Author name et al.\u201d, not \u201cIn our previous work.\u201d The blinded manuscript should contain title, abstract, keywords, main article with references, tables, and figure legends<\/p>\n Abstract:<\/strong> This should start on page 2 of the manuscript. The abstract must not exceed 350 words. Do not use abbreviations or references in the abstract. The structured abstract should consist of four paragraphs: Background (including the context and purpose of the research), Methods, Results, and Conclusions. The abstract should be typed on a separate page, and should not include abbreviations, footnotes, or references. The abstract should make clear how the paper adds to the Orthopaedic literature:<\/p>\n Keywords:<\/strong> Add 3 to 5 keywords at the end of the abstract. MESH terms will be preferable<\/p>\n Blinded Manuscript:<\/strong> The length of the text and references should not exceed 15 pages of double-spaced type. The number of figures and tables together should not exceed 20. Do not repeat in the text all data that appear in the tables or illustrations; emphasize or summarize only important observations. A conclusion may be included in the summary paragraph of the Discussion only if it is not redundant.<\/p>\n The blinded manuscript should not contain the names of the author or their institute. References should be numbered in order of appearance and should be placed in square brackets [1]. The manuscript is usually, but not necessarily, divided into sections with the headings Introduction, Materials and Methods, Results, Discussion, and Clinical Relevance. Long articles may need section subheadings to clarify their content.<\/p>\n Introduction<\/strong>: should explain the background of the case, including the disorder, usual presentation and progression, and an explanation of the presentation if it is a new disease. If it is a case discussing an adverse drug interaction the introduction should give details of the drug’s common use and any previously reported side effects. It should also include a brief literature review.<\/p>\n Material & Methods<\/strong> should be sufficiently detailed to allow easy understanding and reproduction of the study. Details of study design, outcome measures, outcome assessors, and statistical methods have to be provided here. Surgical technique should be described in detail with photographs and videos [videos should be uploaded on Youtube and link to be submitted to us]<\/p>\n Results:<\/strong> Keep results very succinct and to the point. Write all data in mean \u00b1 SD [Range] with appropriate standard units. Mention p values till third decimal points. Use tables to display the numerical data. Do not interpret the results in this section. Provide details of complication events and their individual follow-ups<\/p>\n Discussion:<\/strong> should be elaborate and should focus on the main results of your study. Individual results should be addressed separately and put in context with the current literature.<\/p>\n Clinical relevance: of the study should be mentioned in three or four sentences<\/p>\n Additional Details<\/strong><\/p>\n Abbreviations (if any)<\/strong><\/p>\n If abbreviations are used in the text they should either be defined in the text where first used, or a list of abbreviations can be provided.<\/p>\n Consent<\/strong><\/p>\n This section is compulsory. It should provide a statement to confirm that the patient has given their informed consent for the case report to be published. You do not need to send the form to us on submission, but we may request to see a copy at any stage (including after publication<\/p>\n Conflict of interests<\/strong><\/p>\n Please declare whether competing interest exists. A competing interest exists when your interpretation of data or presentation of information may be influenced by your personal or financial relationship with other people or organizations. Where an author gives no competing interests, the listing must read: \u201cThe author(s) declare that they have no competing interests”.<\/p>\n Download Conflict of Interest form [Click Here]\u00a0<\/span><\/a><\/p>\n Acknowledgments<\/strong><\/p>\n Please acknowledge anyone who contributed towards the study by making substantial contributions to conception, design, acquisition of data, or analysis and interpretation of data, or who was involved in drafting the manuscript or revising it critically for important intellectual content, but who does not meet the criteria for authorship.<\/p>\n References<\/strong><\/p>\n Authors are responsible for verifying the accuracy and completeness of the references. The number of references should not exceed 50. The style of the references should follow the MEDLINE\/ PubMed Journal Article Citation Format found at the National Center for Bibliography Information [NCBI] Website where specific reference citations can be searched for. Abbreviations of journal names must conform to those used in MEDLINE\/PubMed. Avoid using abstracts as references. In the references, do not list personal communications and unpublished material (including oral and poster presentations and manuscripts not yet accepted for publication).<\/p>\n All references must be numbered consecutively, in square brackets, in the order in which they are cited in the text, followed by any in tables or legends. The must be no more than 50 references listed, e.g.<\/p>\n For an article within a journal:<\/strong><\/p>\n Bentolila V, Nizard R, Bizot P, Sedel L. Complete traumatic brachial plexus palsy. Treatment and outcome after repair. J Bone Joint Surg Am 1999;81:20-8.<\/p>\n For a book chapter, or article within a book<\/strong><\/p>\n Songcharoen P. Neurotization in the treatment of brachial plexus injury. In: Omer G, Spinner M, van Beek A, editors. Management of peripheral nerve problems. Philadelphia: W.B. Saunders; 1998. p. 459-64.<\/p>\n If a non-English-language reference is listed, the original language should be indicated, as shown in the following sample:<\/p>\n Journal article not in English Case Reports: Case reports will be considered for publication if they contribute to an understanding of the diagnosis, treatment, and\/or pathogenesis of diseases related to orthopedic surgery. Manuscripts should include the headings Introduction, Report of the case, and Discussion. Do not forget to clearly indicate that consent for publication has been obtained from the patient or his\/her nearest relative.<\/p>\n Case Image: is a description of a single image that has a unique learning point. It should not exceed 1000 words and should have headings of abstract, keywords, case image, discussion, conclusion, clinical message, references, figures, and figure legends.<\/p>\n Technical Note and Video Technique: detailed description of a new technique or improvisation of an old technique. It should not exceed 1000 words and should have headings of abstract, keywords, Technical notes, discussion, conclusion, clinical message, references, figures, and figure legends.<\/p>\n Surgical Tips: Small surgical tips and pearls are invited for this section. Pictures are essential and video will be preferable. It can be a small article from 500 to 1000 words and should include abstract, keywords, Surgical tip, discussion, clinical relevance, references, figures, and figure legends<\/p>\n Case Study: This new format combines the level V evidence with Clinical Decision Making (CDM). It focuses on getting the thought process of the treating surgeon when dealing with a complex\/complicated case. It should not exceed 2500 words and should include a structured abstract, keywords, background, Case introductions, case history, Case Assessment, Case Conceptualization, Management Options, treatment is given, Implications of the case, Clinical recommendations, acknowledgments, references, Figures, and figure legend. For more details, authors can read the case study published in the Journal of orthopedic case reports titled \u201cInfected Nonunion of Radius and Ulna \u2013Strategy of approach\u201d<\/em><\/p>\n Review Articles: These are commissioned, as authors are invited by the editor to contribute review articles.<\/p>\n Letters to the Editor: Letters to the editor of sufficient interest about published articles will be considered for publication. Letters should be typed double-spaced and limited to 1000 words. A copy of the letter will be sent to the previous article\u2019s author(s) to invite a response.<\/p>\n Preparing illustrations and figures:<\/strong><\/p>\n Please note that the Journal of Bone and Soft Tissue Tumors can only publish ten figures in each article. If you have more than ten figures and feel that all are essential to the understanding, please make this clear in your covering letter, explaining why the figures are needed. Figures and tables should be sequentially referenced. Authors should include all relevant supporting data with each article.<\/p>\n Figures should be provided as separate files and should not be included in the main text of the submitted manuscript or include within them the figure legend. Each figure should comprise only a single file. There is no charge for the use of color.\u00a0 Authors should make every effort to preserve the anonymity of the patient by removing or concealing any identifiable features, including birthmarks and tattoos. Please take extra care with images of the head and face, ensuring that only the relevant features are shown. Publication of facial images will be subject to approval by the Editor-in-Chief.<\/p>\n Formats:<\/p>\n The following file formats can be accepted:<\/p>\n EPS (preferred format for diagrams)<\/p>\n PNG (preferred format for photos or images)<\/p>\n TIFF<\/p>\n JPEG<\/p>\n HIGH-RESOLUTION PICTURES ARE NECESSARY<\/p>\n Figure legends: No more than 10 figures per article is accepted. For each figure, the following information should be provided: Figure number (in sequence, using Arabic numerals – i.e. Figure 1, 2, 3, etc); short title of figure (maximum 15 words); detailed legend, up to 300 words. Figures should be provided as separate files. The legends should be included in the main manuscript text file rather than being a part of the figure file. For each figure, the following information should be provided: Figure number (in sequence, using Arabic numerals – i.e. Figure 1, 2, 3, etc); short title of figure (maximum 15 words); detailed legend, up to 300 words. The legend should include a brief description of the exact location of the image on the patient, the type of image (e.g. micrograph\/x-ray), and time in relation to progression e.g. one week after surgery. There must be no abbreviations unless they are expanded (excluding common abbreviations such as antibodies). Please note that it is the responsibility of the author(s) to obtain permission from the copyright holder to reproduce figures or tables that have previously been published elsewhere.<\/p>\n Tables: to be added to the blinded manuscript after the references. Tables should be given a brief, informative title and numbered consecutively in the order of their citation in the text. Type each table double spaced on a separate page. Use the table function in MICROSOFT WORD, not spreadsheets, to make tables. Tables must be no larger than a single sheet of A4 paper. The table number and title should appear above the table, and the definition of all abbreviations, levels of statistical significance, and additional information should appear below the table.<\/p>\n Preparing tables: Each table should be numbered in sequence using Arabic numerals (i.e. Table 1, 2, 3, etc.). Tables should also have a title that summarizes the whole table, a maximum of 15 words. Detailed legends may then follow, but should be concise.<\/p>\n Smaller tables considered to be integral to the manuscript can be pasted into the document text file. Such tables should be formatted using the ‘Table object’ in a word processing program to ensure that columns of data are kept aligned when the file is sent electronically for review.<\/p>\n Tabular data provided as additional files can be uploaded as an Excel spreadsheet (.xls) or comma-separated values (.csv). As with all files, please use the standard file extensions.<\/p>\n Journal of Bone and Soft Tissue Tumors also allows movies and\/or animations to be included as additional files and allows movies to be viewed in the context of the article. Video files should be sent to us by email to editor.jbst@gmail.com<\/a> or can be uploaded to Youtube and link send to us.<\/p>\n Additional data files should be referenced explicitly by file name within the body of the article, e.g. ‘See additional file 1: Movie1 for the original data used to perform this analysis.<\/p>\n Ethics<\/strong><\/p>\n It is the responsibility of the authors to assure that all clinical investigations detailed in manuscripts submitted to the journal are conducted in accordance with the World Medical Association Declaration of Helsinki (www.wma.net\/ en\/30publications\/10policies\/b3\/index.html). All case reports must include a statement indicating that informed consent has been obtained from the patient or appropriate persons for publication, including any necessary photographs. An example of such a statement would be \u201cThe patients and\/or their families were informed that data from the case would be submitted for publication and gave their consent.\u201d Do not use patients\u2019 names, initials, institutional ID numbers, or other identifying information. Articles, including their study design, originating from a particular institution are assumed to be submitted with the approval of the requisite authority on ethical issues. Articles describing research involving human subjects must include a statement in the Materials and methods section indicating that approval was given by the institutional review board (IRB) or Ethics committee of the institution and that informed consent was obtained from each patient or candidate. Manuscripts reporting animal experiments must include a statement in the Materials and methods section indicating that approval was obtained from the institutional review board and that animal care complied with the guidelines of the authors\u2019 institution or any national law on the care and use of laboratory animals.<\/p>\n Policy against Plagiarism<\/strong> Scientific Misconduct<\/strong> For duplicate publication, fabricated data, undisclosed conflict of interest, plagiarism, and\/or other issues of publication and scientific misconduct, Journal of Bone and Soft Tissue Tumors (JBST) follows the guidance produced by Committee on Publication Ethics (COPE) https:\/\/publicationethics.org\/core-practices<\/a>, World Association of Medical Editors (WAME) http:\/\/www.wame.org\/policies-and-resources<\/a> and International Committee of Medical Journal Editors (ICMJE) http:\/\/www.icmje.org\/icmje-recommendations.pdf<\/a>.<\/p>\n Journal of Bone and Soft Tissue Tumors endeavors to avoid all possible misconduct. All manuscripts are checked for plagiarism using iThenticate. If the Editor or a reviewer is concerned that some aspect of a submitted article may constitute misconduct in research, publication, or professional behavior, the Journal communicates the same to the author(s) and seeks clarification. However, if the concerns are not satisfactorily resolved by discussion with the author(s), the Journal may report the same to appropriate authorities such as their institutions and, for duplicate publication, the journal in which the previous publication had appeared.<\/p>\n The Journal also encourages its readers to report any published article in which they suspect misconduct through e-mail or letter. The anonymity of the complainant would be maintained at all times.<\/p>\n Style and language<\/strong><\/p>\n General: Currently, the Journal of Bone and Soft Tissue Tumors can only accept manuscripts written in English. Spelling should be US English or British English, but not a mixture.<\/p>\n It is essential that submitted manuscripts have a high standard of written English. Manuscripts that are poorly written will be returned to authors for revision prior to peer review. Authors are advised to write clearly and simply and to have their articles checked by colleagues before submission. Non-native speakers of English may choose to make use of a copyediting service before submission.<\/p>\n Journal of Bone and Soft Tissue Tumors will copyedit accepted manuscripts before they are published. The editing is designed only to correct such things as misused words, spelling errors, missing references, or incomplete citation information.<\/p>\n Typography <\/strong><\/p>\n Please use double line spacing.<\/p>\n Type the text unjustified, without hyphenating words at line breaks.<\/p>\n Abbreviations spelt out in full for the first time<\/p>\n Numerals from 1 to 10 spelt out<\/p>\n Numerals at the beginning of the sentence spelt out<\/p>\n Use hard returns only to end headings and paragraphs, not to rearrange lines.<\/p>\n Capitalize only the first word, and proper nouns, in the title.<\/p>\n All pages should be numbered.<\/p>\n Use the JBST reference format.<\/p>\n Footnotes to the text should not be used.<\/p>\n Greek and other special characters may be included. If you are unable to reproduce a particular special character, please type out the name of the symbol in full.<\/p>\n Gene names should be in italic, but protein products should be in plain type.<\/p>\n Please ensure that all special characters used are embedded in the text, otherwise, they will be lost during manuscript processing.<\/p>\n Genes, mutations, genotypes, and alleles should be indicated in italics, and authors are required to use approved gene symbols, names, and formatting. Protein products should be in plain type.<\/p>\n Units: SI Units should be used throughout (liter and molar are permitted, however).<\/p>\n Artwork Guidelines<\/strong><\/p>\n Electronic figure submission<\/p>\n Line art<\/p>\n Halftone art<\/p>\n Combination art<\/p>\n Colour art<\/p>\n Figure lettering<\/p>\n Figure numbering<\/p>\n Figure captions<\/p>\n Figure placement and size<\/p>\n Permissions: It is the responsibility of authors\/contributors to obtain permissions for reproducing any copyrighted material. A copy of the permission obtained must accompany the manuscript. Copies of any and all published articles or other manuscripts in preparation or submitted elsewhere that are related to the manuscript must also accompany the manuscript.<\/p>\n Contact Address:<\/strong><\/p>\n Dr. Yogesh Pachwagh<\/p>\n Editor: Journal of Bone and Soft Tissue Tumors (JBST) Journal of Bone and Soft Tissue Tumors (JBST) is open access, Double-blind peer-reviewed journal with contributions from all across the globe. Publishing articles related to care and research in field of bone and soft tissue cancers. Bone and Soft tissue cancers is a rapidly developing area both in terms of diagnostic modalities and innovation […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"jetpack_post_was_ever_published":false,"footnotes":""},"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/P5rNta-1qt","jetpack_likes_enabled":true,"_links":{"self":[{"href":"https:\/\/jbstjournal.com\/wp-json\/wp\/v2\/pages\/5485"}],"collection":[{"href":"https:\/\/jbstjournal.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/jbstjournal.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/jbstjournal.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/jbstjournal.com\/wp-json\/wp\/v2\/comments?post=5485"}],"version-history":[{"count":25,"href":"https:\/\/jbstjournal.com\/wp-json\/wp\/v2\/pages\/5485\/revisions"}],"predecessor-version":[{"id":5487,"href":"https:\/\/jbstjournal.com\/wp-json\/wp\/v2\/pages\/5485\/revisions\/5487"}],"wp:attachment":[{"href":"https:\/\/jbstjournal.com\/wp-json\/wp\/v2\/media?parent=5485"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n
\nemail: editor.jbst@gmail.com
\nwebsite: www.jbstjournal.com<\/p>\n
\n<\/h3>\n
\n\n
\n\n
\n
\n\n
\n
\n
\nOtani T, Hayashi S, Ueno Y, Hayashi H, Kato T, Tamegai H, Fujii K. Long-term radiographic evaluation of muscle release operation for arthritis of the hip: comparison study between the results of muscle release and the natural history of osteoarthritis. Rinshou Seikeigeka (Clinical Orthopaedic Surgery) 2004;39:921\u20136 (in Japanese).<\/p>\n
\n
\nThe Journal follows strict anti-plagiarism policy and defines plagiarism as the duplicate publication of the author\u2019s own work, in whole or in part without proper citation, or mispresenting other\u2019s ideas, words, and other creative expressions as one\u2019s own. All manuscripts submitted to the Journal of Bone and Soft Tissue Tumors (JBST) undergo plagiarism check with the commercially available software iThenticate. Only in cases of minor duplication or similarity with previously published work, the authors may be provided an opportunity to rectify the same; in all other cases, the manuscript is desk rejected along with the plagiarism report (please also see the Scientific Misconduct section for additional details).<\/p>\n
\nIf plagiarism is detected after publication, the Journal will investigate the same, and if established, the authors\u2019 institution and funding bodies would be notified, and the article will be retracted. To report plagiarism, please contact the Journal office, preferably through email for better documentation of correspondence.<\/p>\n\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\nIORG House, A-203, Manthan Apts, Shreesh CHS, Hajuri Road,
\nThane [W]. Maharashtra, India. Pin – 400604
\nEmail: editor.jbst@gmail.com
\nTel: 91-22-25834545<\/p>\n","protected":false},"excerpt":{"rendered":"